Paradigm BioCapital Advisors LP
All holdings · as of Dec 31, 2025
| Company | Value | % of portfolio |
|---|---|---|
| Kalaris Therapeutics, Inc.KLRS | $5.91M | 0.2% |
| INVENTIVA SA | $18.60M | 0.6% |
| Oric Pharmaceuticals, Inc. | $19.64M | 0.6% |
| ASSEMBLY BIOSCIENCES, INC.ASMB | $22.63M | 0.7% |
| Vor Biopharma Inc. | $22.89M | 0.7% |
| BridgeBio Oncology Therapeutics, Inc.BBOT | $28.32M | 0.9% |
| Terns Pharmaceuticals, Inc. | $32.74M | 1.0% |
| Ocular Therapeutix, Inc | $35.63M | 1.1% |
| Viridian Therapeutics, Inc. | $44.91M | 1.4% |
| Lexeo Therapeutics, Inc. | $47.30M | 1.5% |
| SPYRE THERAPEUTICS, INC. | $48.07M | 1.5% |
| Oruka Therapeutics, Inc. | $51.84M | 1.6% |
| BridgeBio Pharma, Inc. | $52.34M | 1.6% |
| Erasca, Inc.ERAS | $52.67M | 1.6% |
| EyePoint, Inc. | $67.44M | 2.1% |
| Apogee Therapeutics, Inc. | $84.78M | 2.6% |
| Crinetics Pharmaceuticals, Inc. | $102.91M | 3.2% |
| UROGEN PHARMA LTD | $104.77M | 3.3% |
| Scholar Rock Holding Corp | $134.89M | 4.2% |
| Edgewise Therapeutics, Inc. | $162.32M | 5.1% |
| CIDARA THERAPEUTICS INC | $167.78M | 5.2% |
| VAXCYTE, INC. | $187.70M | 5.9% |
| Olema Pharmaceuticals, Inc. | $188.60M | 5.9% |
| ABIVAX SA | $191.15M | 6.0% |
| TARSUS PHARMACEUTICALS, INC. | $209.79M | 6.5% |
| GENMAB A/S | $216.83M | 6.8% |
| Arcellx, Inc. | $373.21M | 11.6% |
| Revolution Medicines, Inc. | $529.23M | 16.5% |